These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33389566)

  • 1. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
    Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
    J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma.
    Kruthika BS; Jain R; Arivazhagan A; Bharath RD; Yasha TC; Kondaiah P; Santosh V
    J Neurooncol; 2019 Jan; 141(2):315-325. PubMed ID: 30460633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitinase 3-Like 2.
    Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Chickabasaviah YT; Somanna S; Arivazhagan A; Kondaiah P; Santosh V
    Am J Clin Pathol; 2022 Oct; 158(4):521-529. PubMed ID: 35913110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.
    Lemée JM; Clavreul A; Aubry M; Com E; de Tayrac M; Eliat PA; Henry C; Rousseau A; Mosser J; Menei P
    J Neurooncol; 2015 Mar; 122(1):53-61. PubMed ID: 25559687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
    Lemée JM; Clavreul A; Menei P
    Neuro Oncol; 2015 Oct; 17(10):1322-32. PubMed ID: 26203067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
    Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
    Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. circFLNA promotes glioblastoma proliferation and invasion by negatively regulating miR‑199‑3p expression.
    Sun Y; Ma G; Xiang H; Wang X; Wang H; Zhang Y; Qie F; Li C
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysyl oxidase-like 1 predicts the prognosis of patients with primary glioblastoma and promotes tumor invasion
    Yuan GQ; Zhang G; Nie Q; Wang Z; Gao HZ; Jin GS; Zheng ZQ
    PeerJ; 2024; 12():e17579. PubMed ID: 38978755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
    Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma.
    Lara-Velazquez M; Zarco N; Carrano A; Phillipps J; Norton ES; Schiapparelli P; Al-Kharboosh R; Rincon-Torroella J; Jeanneret S; Corona T; Segovia J; Jentoft ME; Chaichana KL; Asmann YW; Quiñones-Hinojosa A; Guerrero-Cazares H
    Neuro Oncol; 2021 Apr; 23(4):599-610. PubMed ID: 33249487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COL8A1 is a potential prognostic biomarker associated with migration, proliferation, and tumor microenvironment in glioma.
    Liu M; Liang W; Su Y; Wen Y; Qi J; Wang L; Su S; Zhao J; Shan J; Wang J
    Exp Cell Res; 2024 Jun; 439(1):114076. PubMed ID: 38719174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
    Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
    Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
    Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelsolin knockdown confers radiosensitivity to glioblastoma cells.
    Gao D; Jiang T; Liu Y
    Cancer Med; 2024 May; 13(10):e7286. PubMed ID: 38803199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.